恶唑啉|Oxazolines-毕得医药

关于我们|联系我们 400-600-5915|sales@picasso-e.com

登录 | 注册批量下单

搜索购物车会员中心

恶唑啉是一种含氧原子和氮原子的五元杂环化合物。它可能最早合成于1884年，但直到5年后，西格蒙·加布里埃尔才正确地指定了这种结构。它与Hantzsch–Widman命名法一致，是一族杂环化合物的一部分，在饱和度方面它存在于噁唑和噁唑烷之间。

按化学元素: B^x; C^x; N^x; O^x; F^x; Si^x; P^x; S^x; Cl^x; Br^x; I^x

官能团： 酯 (2) 芳基 (7) 酰胺 (1)

母核：

按纯度： 99+% 99% 98+% 98% 97+% 97% 96+% 96% 95+% 95% 93% 90+% 90%

按分子量： 0-100 100-200 200-300 300-400 400-500 500-600

按化学元素： CINO CNOSSi CNOP CClFNO CINOS CBrNO CFINO CNOSi CClNOS COS CNO CNOS CNOSe CFNOS CBrKNO CClFNOS CBrNOS CBrClNO CClNO CBrFNO CBrNOSe CFNO CFNOSe CBNO 更多

(4S,4'S)-2,2'-(4-Bromopyridine-2,6-diyl)bis(4-isopropyl-4,5-dihydrooxazole) (4S,4'S)-2,2'-(4-溴吡啶-2,6-二基)双(4-异丙基-4,5-二氢恶唑): BJS2192296477351-96-598%; ￥1289.00250mg

2,6-Bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)pyridine 2,6-二[(4S)-4-叔丁基-2-噁唑啉基基]吡啶: BJS0606776118949-63-697% 99%ee; ￥3851.005g

1,3-Bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)benzene 1,3-双((S)-4-(叔丁基)-4,5-二氢恶唑-2-基)苯: BJS2869047196207-68-898% 99%ee; ￥1382.00100mg

2,2'-(Propane-2,2-diyl)bis(4,5-dihydrooxazole) 2,2'-(丙烷-2,2-二基)双(4,5-二氢恶唑): BJS3598086165554-94-996%; ￥5286.001g

2-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)pyridine 2-(4,5-二氢-4,4-二甲基-2-恶唑基)吡啶: BJS6243819109660-12-098%; ￥378.00100mg

(3aS,3a'S,8aR,8a'R)-2,2'-(Ethane-1,1-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole) (3aS,3'aS,8aR,8'aR)-2,2'-亚乙基双[3a,8a-二氢-8H-茚并[1,2-d]噁唑]: BJS24604831091605-95-697% 99%ee; ￥2904.00250mg

(R)-4-Isopropyl-2-(4-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole (R)-4-异丙基-2-(4-(三氟甲基)吡啶-2-基)-4,5-二氢噁唑: BJS26560812828432-06-897% 99%ee; ￥968.00100mg

(3aS,8aR)-2-(5-(Trifluoromethyl)pyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole (3aS,8aR)-2-(5-(三氟甲基)吡啶-2-基)-3a,8a-二氢-8H-茚并[1,2-d]噁唑: BJS82308762412578-71-197% 99%ee; ￥712.00250mg

(S)-2-(6-Benzhydrylpyridin-2-yl)-4-(tert-butyl)-4,5-dihydrooxazole (S)-2-(6-二苯甲基吡啶-2-基)-4-(叔丁基)-4,5-二氢恶唑: BJS84265592570984-82-497% 99%ee; ￥1590.0050mg

(4R,4'R)-2,2'-(Pentane-3,3-diyl)bis(4-methyl-4,5-dihydrooxazole) (4R,4'R)-2,2'-(戊烷-3,3-二基)双(4-甲基-4,5-二氢恶唑): BJS72639032828432-10-497%; ￥1428.00100mg

(4R,4'R)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4-methyl-4,5-dihydrooxazole) (4R,4'R)-2,2'-(1-苯基丙烷-2,2-二基)双(4-甲基-4,5-二氢恶唑): BJS59340252757082-30-597%; ￥806.00100mg

(4R,4'R)-4,4'-Diisobutyl-4,4',5,5'-tetrahydro-2,2'-bioxazole (4R,4'R)-4,4'-二异丁基-4,4',5,5'-四氢-2,2'-双恶唑: BJS17669362270178-45-397%; ￥5349.001g

(4S,4'S)-2,2'-(Propane-2,2-diyl)bis(4-isobutyl-4,5-dihydrooxazole) (4S,4'S)-2,2'-(丙烷-2,2-二基)双(4-异丁基-4,5-二氢恶唑): BJS5913004176650-26-397%; ￥517.00100mg

(S)-2-(5-Bromopyridin-2-yl)-4-isopropyl-4,5-dihydrooxazole (S)-2-(5-溴吡啶-2-基)-4-异丙基-4,5-二氢恶唑: BJS30471682757083-25-197% 99%ee; ￥10599.001g

(R)-2-(5-Bromopyridin-2-yl)-4-isopropyl-4,5-dihydrooxazole (R)-2-(5-溴吡啶-2-基)-4-异丙基-4,5-二氢恶唑: BJS36438832757083-30-897% 99%ee; ￥6094.001g

(R)-2-(5-Bromopyridin-2-yl)-4-phenyl-4,5-dihydrooxazole (R)-2-(5-溴吡啶-2-基)-4-苯基-4,5-二氢恶唑: BJS94961052757083-31-997% 99%ee; ￥1964.00100mg

2-(4-Chloropyridin-2-yl)-4,4-dimethyl-4,5-dihydrooxazole 2-(4-氯吡啶-2-基)-4,4-二甲基-4,5-二氢恶唑: BJS95432001137063-15-097%; ￥431.00100mg

(S)-4-((S)-sec-Butyl)-2-(pyridin-2-ylmethyl)-4,5-dihydrooxazole (S)-4-((S)-仲丁基)-2-(吡啶-2-基甲基)-4,5-二氢恶唑: BJS9744780217653-28-697%; ￥386.00100mg

(R)-2-(6-Cyclopropylpyridin-2-yl)-4-isopropyl-4,5-dihydrooxazole (R)-2-(6-环丙基吡啶-2-基)-4-异丙基-4,5-二氢恶唑: BJS43602112828438-53-397%; ￥1869.00100mg

(R)-2-(Benzo[b]thiophen-2-yl)-4-isobutyl-4,5-dihydrooxazole (R)-2-(苯并[b]噻吩-2-基)-4-异丁基-4,5-二氢恶唑: BJS32931502828438-79-395%; ￥779.00100mg

1 2 3 4 5 6 7 8 9 ... 15